NOCTI Guide

The PrEP Shot Costs $40 a Year Abroad. Here It Lists for $28,218

The FDA just tentatively approved a $40-a-year generic of the twice-yearly PrEP shot. Americans can't buy it yet. Here's what it means and what you can do today.

November 2, 2026 · Updated November 2, 2026 at 11:59 AM PST · 4 min read

Shirtless dark-haired man in moody side light gazing off camera, on a NOCTI Your Care Your World cover

The $28,000 Question Nobody Put on the Menu

Picture two guys. Same age, same group-chat energy, same Saturday-night plans. One lives in a country where a twice-a-year HIV prevention shot is about to cost $40 a year. The other lives in the U.S., where the brand-name version of the same medicine lists for $28,218 a year, according to the Press Trust of India's report on the news. Same molecule. Same two shots. A price gap you could buy a used car with. On Monday, the U.S. Food and Drug Administration gave tentative approval to the first generic version of lenacapavir, the long-acting PrEP shot that gay and bi men have been talking about since it launched. The twist? Americans can't buy it.

Plot Twist: The FDA Said Yes. Just Not to You

The generic comes from India's Dr. Reddy's Laboratories, according to Unitaid, one of the global health groups that helped broker the deal. "Tentative" is the FDA's standard label for a generic whose brand-name original is still under patent. Translation: the quality box is checked, but the drug can't be sold here while Gilead's patent stands. Gilead sells the brand-name shot in the U.S. as Yeztugo, which the FDA approved for HIV prevention in June 2025. In late 2024, the company granted voluntary licenses to six generic manufacturers to supply specific lower-income countries, Unitaid says. Dr. Reddy's is the first of those generics to clear the FDA. The price promise is the headline: $40 per person per year. STAT reports that's comparable to the cost of daily PrEP tablets in those programs. So yes, this is a big win. It's just a win with a passport requirement.

“A good plan doesn't kill the mood. Panic does.” — NOCTI

Where the $40 Shots Are Going, and Why You Should Care

The generic is meant for 120 low- and middle-income countries covered by Gilead's license, according to Unitaid. First supplies are expected by the end of 2026, with broader availability in 2027. STAT reports Dr. Reddy's plans to start shipping next month. Demand is already real. More than 125,000 people in 10 early-adopter African countries have started Gilead's version, Unitaid says. And the stakes are enormous: citing the World Health Organization, the Press Trust of India reports that about 41 million people were living with HIV and 570,000 died of HIV-related causes last year. Dr. Neil Buddy Shah, CEO of the Clinton Health Access Initiative, described the shot as "almost 100% effective at preventing HIV." A Gilead spokesperson said, "We share the sense of urgency around expanding access to lenacapavir for HIV prevention." Urgency. Love that word. Now hold it up next to a $28,218 sticker.

NOCTI's take: A Price Tag Shouldn't Decide Who Stays Negative

Cheaper PrEP for the countries carrying the heaviest HIV burden is good news, full stop. Nobody here is mad that a guy in Johannesburg gets a $40 shot. We're mad that the conversation in America still starts with "what does your insurance say?" instead of "when do you want to start?" The CDC estimates more than 31,000 people in the U.S. acquire HIV every year, and 2.2 million Americans could benefit from PrEP. That isn't a science problem anymore. It's a paperwork, pricing and shame problem. And shame is the one we can fix tonight, for free.

Don't Wait for a Patent to Expire. Do This Instead

Here's the part that actually helps. The CDC strongly recommends twice-yearly lenacapavir as one PrEP option, alongside daily pills and cabotegravir shots every two months. One of them can probably fit your life and your budget. 1. Ask for PrEP by name. CDC guidance tells providers to prescribe PrEP to anyone who asks for it. You don't need a dramatic backstory. 2. Ask about all three options. Pills, a shot every two months, or a shot every six months. Pick the one you'll actually stick with. 3. Call your insurer before the appointment. Ask how each option is covered and whether the shot needs prior approval, so the surprise happens on the phone, not at the pharmacy counter. 4. Keep up the testing. You need an HIV test before starting the shot and before each injection. Common side effects include injection-site reactions, headache and nausea, according to the Press Trust of India report. 5. Know your backup. If a condom breaks or a night goes off-script, PEP must be started within 72 hours of exposure and is taken daily for 28 days, the CDC says. Call a doctor, urgent care or an ER right away. No shame, no spiral. Just a plan.

“Two shots a year, zero spirals. Now that's a glow-up.” — NOCTI

The Bottom Line: Protection Isn't Waiting on a Patent

The world just got a $40 PrEP shot, and you can still get protected today with the options already on the shelf. Want men-first care where you never have to explain yourself twice? Start at joinnocti.com/discover. This article is for general information and isn't medical advice.

SourcesPress Trust of India via Business Standard, Unitaid +3 more

Find men’s massage near you

Compare local providers privately and contact the professional you choose directly.

Search NOCTI